DB
David Bredt (Chief Scientific Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Rapport Therapeutics, Inc. (RAPP). The largest single filing was $231K of RAPP (7,704 sh × $29.95, as filed), executed Dec 15 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$807K
shares × price, as filed
Last traded
Feb 17
Filed Feb 19
Median ADV $17.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
RAPPRecent filings
RAPPSALE
Rapport Therapeutics, Inc.
View filing →
$156K5,400 sh × $28.95
Exec Feb 17
Filed Feb 19 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $223K
8,300 sh × $26.83
Exec Jan 15
Filed Jan 16 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $197K
6,567 sh × $30.05
Exec Dec 31 2025
Filed Jan 5 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $231K
7,704 sh × $29.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $136K
5,344 sh × $25.39
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $191K
7,418 sh × $25.73
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $122K
5,098 sh × $23.88
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET RAPPSALE Rapport Therapeutics, Inc. View filing → $124K
8,300 sh × $14.98
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET More filings →